AIM
BSX icon

Anchor Investment Management’s Boston Scientific BSX Stock Holding History

Anchor Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.7K Sell
1,468
-327
-18% -$17.8K ﹤0.01% 582
2026
Q1 		$113K Sell
1,795
-8,291
-82% -$663K 0.01% 463
2025
Q4 		$962K Buy
10,086
+573
+6% +$56.2K 0.08% 203
2025
Q3 		$929K Buy
9,513
+1,199
+14% +$124K 0.08% 200
2025
Q2 		$893K Buy
8,314
+669
+9% +$67.7K 0.08% 197
2025
Q1 		$771K Sell
7,645
-493
-6% -$49.6K 0.07% 210
2024
Q4 		$727K Buy
8,138
+7,962
+4,524% +$701K 0.07% 215
2024
Q3 		$14.7K Buy
176
+46
+35% +$3.63K ﹤0.01% 733
2024
Q2 		$10K Hold
130
– – ﹤0.01% 751
2024
Q1 		$8.9K Hold
130
– – ﹤0.01% 802
2023
Q4 		$7.51K Hold
130
– – ﹤0.01% 787
2023
Q3 		$6.86K Hold
130
– – ﹤0.01% 800
2023
Q2 		$7.03K Sell
130
-120
-48% -$6.27K ﹤0.01% 787
2023
Q1 		$12.5K Hold
250
– – ﹤0.01% 711
2022
Q4 		$11.6K Sell
250
-91
-27% -$3.94K ﹤0.01% 699
2022
Q3 		$13.2K Sell
341
-2,464
-88% -$98.8K ﹤0.01% 685
2022
Q2 		$105K Buy
2,805
+2,555
+1,022% +$104K 0.02% 446
2022
Q1 		$11.1K Hold
250
– – ﹤0.01% 743
2021
Q4 		$10.6K Hold
250
– – ﹤0.01% 777
2021
Q3 		$10.8K Hold
250
– – ﹤0.01% 709
2021
Q2 		$10.7K Hold
250
– – ﹤0.01% 725
2021
Q1 		$9.66K Hold
250
– – ﹤0.01% 710
2020
Q4 		$8.99K Hold
250
– – ﹤0.01% 686
2020
Q3 		$9.55K Buy
250
+130
+108% +$5.01K ﹤0.01% 664
2020
Q2 		$4.21K Hold
120
– – ﹤0.01% 725
2020
Q1 		$3.92K Buy
+120
New +$4.69K ﹤0.01% 713

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Anchor Investment Management's BSX Position: Q2 2026 in Review

Anchor Investment Management reduced its Boston Scientific (BSX) stake by 18% in Q2 2026, selling an estimated $17.8K and leaving 1,468 shares worth $62.7K. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Anchor Investment Management first reported a position in BSX in Q1 2020 and has held it in 26 quarters since. The position peaked at $962K in Q4 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Anchor Investment Management held 1,468 shares of Boston Scientific worth $62.7K as of Q2 2026.
  • Anchor Investment Management sold 327 Boston Scientific shares in Q2 2026, an estimated $17.8K.
  • Boston Scientific made up ﹤0.01% of Anchor Investment Management's portfolio in Q2 2026, its #582 holding.
  • Anchor Investment Management first reported a position in Boston Scientific in Q1 2020 and has held it in 26 quarters since.
  • Anchor Investment Management's Boston Scientific position peaked at $962K in Q4 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Anchor Investment Management's 13F filing for Q2 2026, filed 15 Sep 2026.